XML 46 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue (Tables)
 12 Months Ended
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:
 
For the year ended
December 31,
 
2019
 
2018
 
2017
Product line
Revenue
 
% of Revenue
 
Revenue
 
% of Revenue
 
Revenue
 
% of Revenue
Infusion Consumables
$
477,611

 
37
%
 
$
483,039

 
35
%
 
$
365,665

 
28
%
Infusion Systems
328,282

 
26
%
 
355,484

 
25
%
 
290,207

 
23
%
IV Solutions
414,971

 
33
%
 
507,985

 
36
%
 
521,963

 
40
%
Critical Care
45,344

 
4
%
 
53,532

 
4
%
 
49,961

 
4
%
Other
—

 
—
%
 
—

 
—
%
 
64,817

 
5
%
Total Revenues
$
1,266,208

 
100
%
 
$
1,400,040

 
100
%
 
$
1,292,613

 
100
%
    
We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.    
    
The following table represents our revenues disaggregated by geography (in thousands):
 
For the year
ended December 31,
Geography
2019
 
2018
 
2017
Europe, the Middle East and Africa
$
130,530

 
$
134,363

 
$
119,934

Other Foreign
212,336

 
210,996

 
192,640

Total Foreign
342,866

 
345,359

 
312,574

United States
923,342

 
1,054,681

 
980,039

Total Revenues
$
1,266,208

 
$
1,400,040

 
$
1,292,613


Domestic sales accounted for 73%, 75% and 76% of total revenue in 2019, 2018 and 2017, respectively. International sales accounted for 27%, 25% and 24% of total revenue in 2019, 2018 and 2017, respectively.
Contract with Customer, Asset and Liability [Table Text Block]

Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10, Accrued Liabilities and Other Long-term liabilities). The following table presents our changes in the contract balances for the years ended December 31, 2019 and 2018, (in thousands):
 
Contract Liabilities
Beginning balance, January 1, 2018
$
(7,066
)
Equipment revenue recognized
6,696

Equipment revenue deferred due to implementation
(4,196
)
Software revenue recognized
6,553

Software revenue deferred due to implementation
(6,269
)
Ending balance, December 31, 2018
$
(4,282
)
Equipment revenue recognized
8,807

Equipment revenue deferred due to implementation
(8,794
)
Software revenue recognized
3,953

Software revenue deferred due to implementation
(4,539
)
Ending balance, December 31, 2019
$
(4,855
)